CRISPR Therapeutics

We’re proud to have presented our latest findings at the American Society of Hematology (ASH) 2024 Annual Meeting earlier this week. Thank you to our incredible team for their hard work, dedication, and collaboration in making this possible. It’s inspiring to share progress and innovation with the broader scientific community as we continue advancing our programs. #ASH24

We’re pleased to provide an update on our ongoing Phase 1/2 dose escalation clinical trial evaluating the safety and efficacy of CTX112™, a next-generation CD19 allogeneic CAR T cell therapy, in relapsed or refractory (R/R) CD19-positive B-cell malignancies at the American Society of Hematology (ASH) 2024 Annual Meeting. Learn more here: https://bit.ly/4ivSCZB #ASH24

We are thrilled that the 2024 Scrip Awards recognized our pioneering work and innovation in drug discovery and development for patients. Congratulations to all the winners across categories! #ScripAwards

Today, we announced our third quarter earnings results. Read more about our recent highlights and outlook in our business update: https://bit.ly/3UElR2b #CRSP #CRISPRTX 

We are honored to share that we've been nominated for the Patient Impact Award at the 12th Annual NEVY Awards! Thank you to the New England Venture Capital Association (NEVCA) for recognizing us. Please read the #NEVCA blog post for more details: https://bit.ly/4hBx1yr

We’re proud to share that we’ve been named on the TIME Best Inventions of 2024 list! This list recognizes a wide variety of new products, software or services that are making a difference in the world. #TIMEBestInventions

#WorldHeartDay aims to raise awareness for #cardiovasculardiseases, a variety of complications affecting the heart and blood vessels. These complications result in more than 20.5 million deaths each year. Learn more about cardiovascular diseases here: https://bit.ly/3YRStbN

Did you know that familial hypercholesterolemia, or #FH, is one of the most common genetic causes of high cholesterol? In recognition of #FHAwarenessDay, learn more about this condition at the Family Heart Foundation's website: https://bit.ly/3WvAFjE

Leaders across the healthcare ecosystem will join forces at the annual World Medical Innovation Forum in Boston to discuss the industry’s latest trends, developments, and outlook. Our CEO and Chairman Dr. Samarth Kulkarni and our CFO Dr. Raju Prasad will be speaking on panels on Monday, September 23rd about the broad potential for genetic medicines. Learn more about #WMIF2024 here: https://lnkd.in/evjGVi-p

A 39-year-old man from Atlanta has become the world’s first person with sickle cell disease (SCD) to reach the summit of Kilimanjaro. He climbed Kilimanjaro with the Timmerman Traverse group that’s raising awareness for #SCD. #SickleCellAwarenessMonth